Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
about
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Costs and cost-efficacy analys ...... herapy in HIV-infected adults.
@en
type
label
Costs and cost-efficacy analys ...... herapy in HIV-infected adults.
@en
prefLabel
Costs and cost-efficacy analys ...... herapy in HIV-infected adults.
@en
P2093
P50
P1476
Costs and cost-efficacy analys ...... therapy in HIV-infected adults
@en
P2093
Antonio Javier Blasco
Esteban Martínez
Federico Pulido
Fernando Lozano
Javier de la Torre
Jesús Santos
Josep M Gatell
José Antonio Iribarren
José López-Aldeguer
José Ramón Arribas
P304
P356
10.1016/J.EIMC.2017.04.002
P577
2017-05-19T00:00:00Z